Editorial: How much is your eyesight worth to you?
by Chicago Tribune
Jan 05, 2018
2 minutes
Spark Therapeutics recently launched a pioneering new drug that can improve the vision of patients with a rare hereditary form of vision loss. That's not the only thing that is pioneering about this drug, called Luxturna. Its price is, too. Spark announced this week that treatment will cost $850,000 a patient. "We believe that
You’re reading a preview, subscribe to read more.
Start your free 30 days